Moreover, the pathogenesis of alopecia areata is believed to involve inflammatory cytokines IL-17A and monoclonal antibodies against IL-17A secukinumab-caused hair regrowth in human volunteers [55]. This evidence concerns the gene IL17A and alopecia areata.